COVID-19 Impact on Biochips Market, Global Research Reports 2020-2021

Code: QYRE-Auto-1O3049

Report

May 2020

Pages:94

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Thermo Fisher Scientific

SuperBioChips Laboratories

US Biomax

Roche Diagnostics

Company

This report covers market size and forecasts of Biochips, including the following market information:

Global Biochips Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Biochips Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Biochips Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

Global Biochips Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include Abbott, Agilent Technologies, Illumina, PerkinElmer, Thermo Fisher Scientific, BioChain, Bio-Rad Laboratories, Cepheid, EMD Millipore, Fluidigm, SuperBioChips Laboratories, US Biomax, Roche Diagnostics, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

DNA Chip

Lab-on-a-Chip

Protein Chip

Others

Based on the Application:

Biotechnology and Pharmaceutical Companies

Hospitals and Diagnostics Centers

Academic & Research Institutes

Other End Users

FEATURED COMPANIES

Thermo Fisher Scientific

SuperBioChips Laboratories

US Biomax

Roche Diagnostics

Company

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Biochips Industry

1.7 COVID-19 Impact: Biochips Market Trends

2 Global Biochips Quarterly Market Size Analysis

2.1 Biochips Business Impact Assessment - COVID-19

2.1.1 Global Biochips Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Biochips Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Biochips Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Biochips Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Biochips Factory Price by Manufacturers

3.3 Location of Key Manufacturers Biochips Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Biochips Market

3.5 Key Manufacturers Biochips Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Biochips Segments, By Type

4.1 Introduction

1.4.1 DNA Chip

1.4.2 Lab-on-a-Chip

1.4.3 Protein Chip

1.4.4 Others

4.2 By Type, Global Biochips Market Size, 2019-2021

4.2.1 By Type, Global Biochips Market Size by Type, 2020-2021

4.2.2 By Type, Global Biochips Price, 2020-2021

5 Impact of Covid-19 on Biochips Segments, By Application

5.1 Overview

5.5.1 Biotechnology and Pharmaceutical Companies

5.5.2 Hospitals and Diagnostics Centers

5.5.3 Academic & Research Institutes

5.5.4 Other End Users

5.2 By Application, Global Biochips Market Size, 2019-2021

5.2.1 By Application, Global Biochips Market Size by Application, 2019-2021

5.2.2 By Application, Global Biochips Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Abbott

7.1.1 Abbott Business Overview

7.1.2 Abbott Biochips Quarterly Production and Revenue, 2020

7.1.3 Abbott Biochips Product Introduction

7.1.4 Abbott Response to COVID-19 and Related Developments

7.2 Agilent Technologies

7.2.1 Agilent Technologies Business Overview

7.2.2 Agilent Technologies Biochips Quarterly Production and Revenue, 2020

7.2.3 Agilent Technologies Biochips Product Introduction

7.2.4 Agilent Technologies Response to COVID-19 and Related Developments

7.3 Illumina

7.3.1 Illumina Business Overview

7.3.2 Illumina Biochips Quarterly Production and Revenue, 2020

7.3.3 Illumina Biochips Product Introduction

7.3.4 Illumina Response to COVID-19 and Related Developments

7.4 PerkinElmer

7.4.1 PerkinElmer Business Overview

7.4.2 PerkinElmer Biochips Quarterly Production and Revenue, 2020

7.4.3 PerkinElmer Biochips Product Introduction

7.4.4 PerkinElmer Response to COVID-19 and Related Developments

7.5 Thermo Fisher Scientific

7.5.1 Thermo Fisher Scientific Business Overview

7.5.2 Thermo Fisher Scientific Biochips Quarterly Production and Revenue, 2020

7.5.3 Thermo Fisher Scientific Biochips Product Introduction

7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments

7.6 BioChain

7.6.1 BioChain Business Overview

7.6.2 BioChain Biochips Quarterly Production and Revenue, 2020

7.6.3 BioChain Biochips Product Introduction

7.6.4 BioChain Response to COVID-19 and Related Developments

7.7 Bio-Rad Laboratories

7.7.1 Bio-Rad Laboratories Business Overview

7.7.2 Bio-Rad Laboratories Biochips Quarterly Production and Revenue, 2020

7.7.3 Bio-Rad Laboratories Biochips Product Introduction

7.7.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments

7.8 Cepheid

7.8.1 Cepheid Business Overview

7.8.2 Cepheid Biochips Quarterly Production and Revenue, 2020

7.8.3 Cepheid Biochips Product Introduction

7.8.4 Cepheid Response to COVID-19 and Related Developments

7.9 EMD Millipore

7.9.1 EMD Millipore Business Overview

7.9.2 EMD Millipore Biochips Quarterly Production and Revenue, 2020

7.9.3 EMD Millipore Biochips Product Introduction

7.9.4 EMD Millipore Response to COVID-19 and Related Developments

7.10 Fluidigm

7.10.1 Fluidigm Business Overview

7.10.2 Fluidigm Biochips Quarterly Production and Revenue, 2020

7.10.3 Fluidigm Biochips Product Introduction

7.10.4 Fluidigm Response to COVID-19 and Related Developments

7.11 SuperBioChips Laboratories

7.11.1 SuperBioChips Laboratories Business Overview

7.11.2 SuperBioChips Laboratories Biochips Quarterly Production and Revenue, 2020

7.11.3 SuperBioChips Laboratories Biochips Product Introduction

7.11.4 SuperBioChips Laboratories Response to COVID-19 and Related Developments

7.12 US Biomax

7.12.1 US Biomax Business Overview

7.12.2 US Biomax Biochips Quarterly Production and Revenue, 2020

7.12.3 US Biomax Biochips Product Introduction

7.12.4 US Biomax Response to COVID-19 and Related Developments

7.13 Roche Diagnostics

7.13.1 Roche Diagnostics Business Overview

7.13.2 Roche Diagnostics Biochips Quarterly Production and Revenue, 2020

7.13.3 Roche Diagnostics Biochips Product Introduction

7.13.4 Roche Diagnostics Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Biochips Supply Chain Analysis

8.1.1 Biochips Supply Chain Analysis

8.1.2 Covid-19 Impact on Biochips Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Biochips Distribution Channels

8.2.2 Covid-19 Impact on Biochips Distribution Channels

8.2.3 Biochips Distributors

8.3 Biochips Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

SuperBioChips Laboratories

US Biomax

Roche Diagnostics

Company

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Biochips Assessment

Table 9. COVID-19 Impact: Biochips Market Trends

Table 10. COVID-19 Impact Global Biochips Market Size

Table 11. Global Biochips Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Biochips Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Biochips Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Biochips Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Biochips Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Biochips Market Growth Drivers

Table 17. Global Biochips Market Restraints

Table 18. Global Biochips Market Opportunities

Table 19. Global Biochips Market Challenges

Table 20. Key Manufacturers Biochips Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Biochips Market Size, 2019 (K Units) & (US$ Million)

Table 22. Biochips Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Biochips Manufacturing Plants

Table 24. Key Manufacturers Biochips Market Served

Table 25. Date of Key Manufacturers Enter into Biochips Market

Table 26. Key Manufacturers Biochips Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Biochips Market Size by Type, 2020, (US$ Million)

Table 29. Global Biochips Market Size by Type, 2020 (K Units)

Table 30. Global Biochips Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Biochips Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Biochips Market Size by Application, 2020-2021 (K Units)

Table 33. Global Biochips Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Biochips Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Biochips Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Biochips Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Biochips Market Size, 2019-2021 (K Units)

Table 38. US Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Biochips Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Biochips Market Size, 2019-2021 (K Units)

Table 43. Germany Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Biochips Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Biochips Market Size, 2019-2021 (K Units)

Table 50. China Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Biochips Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. Abbott Business Overview

Table 58. Abbott Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Abbott Biochips Product

Table 60. Abbott Response to COVID-19 and Related Developments

Table 61. Agilent Technologies Business Overview

Table 62. Agilent Technologies Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Agilent Technologies Biochips Product

Table 64. Agilent Technologies Response to COVID-19 and Related Developments

Table 65. Illumina Business Overview

Table 66. Illumina Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Illumina Biochips Product

Table 68. Illumina Response to COVID-19 and Related Developments

Table 69. PerkinElmer Business Overview

Table 70. PerkinElmer Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. PerkinElmer Biochips Product

Table 72. PerkinElmer Response to COVID-19 and Related Developments

Table 73. Thermo Fisher Scientific Business Overview

Table 74. Thermo Fisher Scientific Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Thermo Fisher Scientific Biochips Product

Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments

Table 77. BioChain Business Overview

Table 78. BioChain Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. BioChain Biochips Product

Table 80. BioChain Response to COVID-19 and Related Developments

Table 81. Bio-Rad Laboratories Business Overview

Table 82. Bio-Rad Laboratories Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Bio-Rad Laboratories Biochips Product

Table 84. Bio-Rad Laboratories Response to COVID-19 and Related Developments

Table 85. Cepheid Business Overview

Table 86. Cepheid Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Cepheid Biochips Product

Table 88. Cepheid Response to COVID-19 and Related Developments

Table 89. EMD Millipore Business Overview

Table 90. EMD Millipore Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. EMD Millipore Biochips Product

Table 92. EMD Millipore Response to COVID-19 and Related Developments

Table 93. Fluidigm Business Overview

Table 94. Fluidigm Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Fluidigm Biochips Product

Table 96. Fluidigm Response to COVID-19 and Related Developments

Table 97. SuperBioChips Laboratories Business Overview

Table 98. SuperBioChips Laboratories Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. SuperBioChips Laboratories Biochips Product

Table 100. SuperBioChips Laboratories Response to COVID-19 and Related Developments

Table 101. US Biomax Business Overview

Table 102. US Biomax Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. US Biomax Biochips Product

Table 104. US Biomax Response to COVID-19 and Related Developments

Table 105. Roche Diagnostics Business Overview

Table 106. Roche Diagnostics Biochips Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Roche Diagnostics Biochips Product

Table 108. Roche Diagnostics Response to COVID-19 and Related Developments

Table 109. Biochips Distributors List

Table 110. Biochips Customers List

Table 111. Covid-19 Impact on Biochips Customers

List of Figures

Figure 1. Biochips Product Picture

Figure 2. Biochips Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Biochips Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Biochips Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Biochips Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Biochips Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Biochips Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Biochips Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Biochips Market Size Market Share, 2019-2021

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3250

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$4875

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

COVID-19 Impact on Biochips Market, Global Research Reports 2020-2021

Published Date: May 2020

Report Code: QYRE-Auto-1O3049

COVID-19 Impact on Biochips Market, Global Research Reports 2020-2021

FEATURED COMPANIES

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions